## TROW: T. Rowe Price Group, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 3.0% below STRENGTH zone (3.0-6.0%); PEG 4.90 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($99.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Kestra Investment Management LLC Sells 21,334 Shares of T. Rowe Price Group, Inc. $TROW**
- Source: MarketBeat | 20251215T104159 | Neutral | Relevance: 100%
- Kestra Investment Management LLC significantly reduced its stake in T. Rowe Price Group, Inc. ($TROW) during the second quarter, selling 21,334 shares for an approximate value of $1.36 million. Despite this, T. Rowe Price delivered strong quarterly earnings, beating analyst estimates, and declared a $1.27 quarterly dividend, reflecting a 4.8% yield. The company currently holds a "Reduce" rating from analysts with an average target price of $108.85.

**2. T. Rowe Price Group (NASDAQ:TROW) Price Target Raised to $128.00**
- Source: MarketBeat | 20251217T144308 | Neutral | Relevance: 100%
- Morgan Stanley raised its price target for T. Rowe Price Group (NASDAQ:TROW) to $128.00 from $126.00, reiterating an "equal weight" rating, which suggests a potential upside of approximately 21.8% from the current share price. Despite this, the overall analyst sentiment remains cautious, with a consensus price target of $108.85 and a "Reduce" rating from MarketBeat, based on 12 Hold and 4 Sell ratings. T. Rowe Price recently exceeded earnings expectations, reporting an EPS of $2.81 against an estimate of $2.55 and revenue of $1.89 billion, a 6% year-over-year increase.

**3. Keefe, Bruyette & Woods Cuts Price Target on T. Rowe to $115 From $117, Maintains Market Perform Rating**
- Source: marketscreener.com | 20251216T120839 | Somewhat-Bearish | Relevance: 100%
- Keefe, Bruyette & Woods has reduced its price target for T. Rowe Price Group (TROW) to $115 from the previous $117. The firm has, however, maintained its "Market Perform" rating for the investment management company. This adjustment reflects an updated outlook by the analyst firm on T. Rowe's valuation.

**4. Goldman, T. Rowe Launch First Co-Branded Portfolio for Wealthy Clients**
- Source: TradingView — Track All Markets | 20251216T170849 | Somewhat-Bearish | Relevance: 96%
- Goldman Sachs Asset Management and T. Rowe Price have launched their first co-branded model portfolios, marking the initial phase of their strategic alliance. These portfolios, offered through GeoWealth’s UMA platform, are designed for mass-affluent and high-net-worth clients, leveraging the expertise of both firms. A fifth model, the "Goldman Sachs T. Rowe Price High Net Worth Portfolio," is anticipated in early 2026.

**5. AI: Potentially the biggest productivity enhancer since electricity?**
- Source: T. Rowe Price | 20251215T180838 | Somewhat-Bullish | Relevance: 95%
- This article argues that Artificial Intelligence could deliver the most significant productivity surge since electrification, surpassing the impact of the internet due to its rapid adoption and transformative applications. Despite speculative risks, the author suggests current AI valuations are more rational than during the dot-com era, as leading companies exhibit strong earnings growth and self-fund infrastructure. The article emphasizes disciplined navigation of AI investments, focusing on "linchpin" technologies, cash-rich innovators, and companies with improving fundamentals and reasonable valuations.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Keefe, Bruyette | $115 | $117 | -2% |
| 2025-12-17 | Morgan Stanley | $128 | $126 | +2% |
| 2025-12-12 | Barclays | $102 | $101 | +1% |
| 2025-12-05 | Evercore ISI Gr | $115 | $118 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Keefe, Bruyette | main | Market Perform |
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-12 | Barclays | main | Underweight |
| 2025-12-05 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 22 ($0.55M) |
| Sells | 11 ($7.33M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.1% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-0.1%)
- Blackrock Inc.: 9.4% (-1.6%)
- State Street Corpora: 6.5% (-2.7%)
- Charles Schwab Inves: 3.6% (+1.1%)
- Geode Capital Manage: 2.8% (+1.0%)

### Key Risks

1. Insider selling cluster: $7.3M in recent transactions.
2. Valuation stretched: PEG 4.9x requires aggressive growth execution.
3. Elevated short interest (8.8%): bears positioning against stock.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.90 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROA 10%, margin 29%). Balance sheet: strong liquidity (11.4x), low leverage (D/E 0.26). Insider selling cluster ($7.3M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $22.8B |
| Beta | 1.54 |
| 52W Range | $77.85 - $118.89 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.90 |
| Forward P/E | 10.1 |
| Current P/E | 10.7 |
| YoY Growth | 5.9% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 0.3% to 3.0% (+2.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.0pp (needs >3.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 52. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.96% (CS: 57) | Neutral |
| RSI_14 | 52.3 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.045x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $103.90
- **Stop Loss:** $99.62 (4.1% risk)
- **Target:** $108.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 252
- **Position Value:** $26,182.80
- **Portfolio %:** 26.18%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-06 (Est: $2.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.54 | $2.81 | +10.5% |
| 2025Q2 | $2.13 | $2.24 | +4.9% |
| 2025Q1 | $2.13 | $2.23 | +4.7% |
| 2024Q4 | $2.21 | $2.12 | -4.1% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*